Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness?

BioPharma DiveEarly data for heart drug affirm Lilly’s billion-dollar bet on Verve

BioPharma DiveLilly dives into vaccine research with 3 biotech buyouts

FierceBiotechMakary’s FDA reforms ‘continue to move forward’ despite leadership turmoil

Clinical OMICsGPS Tracking Upends Rural Uganda’s Schistosomiasis Transmission Assumptions

Endpoints NewsCartesian secures funding to 'accelerate' launch; Editas sells $125M in stock

Endpoints NewsCan AI do scientific research? Billions chase hopes of superintelligence

BioWorldChina’s new IIT rules expected to wipe out ‘gray market’

BioWorldDaewoong takes over Turn Bio’s longevity platform from Hanall

BioWorldTennor’s $80M Hong Kong IPO to fund antibacterial drug pipeline

BioWorldAI, remote care drive new models for Australian medtech

BioWorldBiggest gainers and losers for May 18-22, 2026

FierceBiotechKura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential